Our Mission is to provide high quality peptides quickly and efficiently, to ensure complete customer satisfaction.

We are a dedicated team of highly qualified individuals ready to address your most challenging peptide requirements. By developing our peptide synthesis robots in-house, we have full control over the manufacturing process.

This means we can assure highest quality and respond quickly and flexibly to all research requirements. To achieve this, we draw on 23 years of experience in peptide synthesis and robot development.

Dr. Oliver Kreuzer: Combining peptide expertise and in depth technical knowledge

peptides&elephants was established in 2001 by Dr. Oliver J. Kreuzer and fellow researchers from the German Institute of Human Nutrition in Potsdam and the Charité in Berlin.

Dr. Kreuzer has had a long-standing passion for peptides. His diploma thesis in Chemical Engineering already centered around automated peptide processing. He continued this focus at Evotec, where he started to create his first peptide synthesis robot. His doctoral thesis on hormone receptors then led him to explore the user side of peptide chemistry. Experienced in both fields and equipped with an entrepreneurial spirit, he and his colleagues established their own company, bringing to life the first high parallel peptide synthesizer.

This company‘s first patented product spurred a major development: It paved the way for super-fast peptide library screening concepts, which have been adapted by peptide CMOs worldwide for use in drug discovery and immune research.

Over the following decades, Dr. Kreuzer evolved into a distinguished peptide expert, acquiring an intimate understanding of every amino acid's unique chemical properties. Coupled with his in-depth technical expertise, he was able to bring to life another groundbreaking invention: the proprietary Ultrasonic Peptide Synthesis USPS® platform. This market-leading technology can synthesize 192 separate peptides in the astonishingly short span of eight hours.